APOA1
apolipoprotein A-I
APOA1; apolipoprotein A-I; apo-AI; Sep2; Alp-1; Ltw-1; Sep-1; Sep-2; Apoa-1; Brp-14; Lvtw-1;
APOD
Apolipoprotein D
APOD protein; Apolipoprotein D; apolipoprotein D OTTHUMP00000208788; ApoD; Apo-D; OTTHUMP00000208787;
APOH
apolipoprotein H (beta-2-glycoprotein I)
APOH; apolipoprotein H (beta-2-glycoprotein I); B2G1; beta-2-glycoprotein 1; beta 2 glycoprotein I; BG; Activated protein C binding protein; Activated protein C-binding protein; Anticardiolipin cofactor; APC inhibitor; Apo-H; APOH; APOH_HUMAN; Apolipoprotein H; B2G1; B2GPI; beta 2 glycoprotein I; beta 2 glycoprotein I precursor; BetaGPI; Beta-2-glycoprotein 1; Beta-2-glycoprotein I; BG; OTTMUSP00000003033; B2GPI; apo-H; betaGPI; APC inhibitor; anticardiolipin cofactor; activated protein C-binding protein; B2GP1;
APOM
apolipoprotein M
APOM; apolipoprotein M; G3a; NG20; protein G3a; NG20-like protein; alternative name: G3a, NG20; apo-M; HSPC336; MGC22400;
PVR
poliovirus receptor
PVR; poliovirus receptor; tumor-associated antigen 1; PVS; mE4; HVED; Taa1; CD155; Tage4; necl-5; D7Ertd458e; 3830421F03Rik;
PVRL1
poliovirus receptor-related 1 (herpesvirus entry mediator C)
PVRL1; poliovirus receptor-related 1 (herpesvirus entry mediator C); ED4; PRR; HIgR; HVEC; OFC7; PRR1; PVRR; CD111; PVRR1; SK-12; CLPED1; nectin-1; poliovirus receptor-related protein 1; nectin 1; poliovirus receptor-like 1; herpesvirus Ig-like receptor; herpes virus entry mediator C; ectodermal dysplasia 4 (Margarita Island type);
Pvrl2
poliovirus receptor-related 2 (herpesvirus entry mediator B)
PVRL2; poliovirus receptor-related 2 (herpesvirus entry mediator B); HVEB; PRR2; CD112; PVRR2; poliovirus receptor-related protein 2; nectin-2; poliovirus receptor-like 2; herpesvirus entry protein B;
PVRL3
poliovirus receptor-related 3
PVRL3; poliovirus receptor-related 3; poliovirus receptor-related protein 3; CD113; CDw113; DKFZP566B0846; nectin 3; PPR3; PVRR3; PRR3; NECTIN-3; FLJ90624;
APOB
apolipoprotein B
APOB; apolipoprotein B; FLDB; LDLCQ4; apolipoprotein B-100; apoB-48; apoB-100; apo B-100; mutant Apo B 100; apolipoprotein B48; apolipoprotein B (including Ag(x) antigen);
APOA5
apolipoprotein A-V
UNQ411/PRO773; APOAV; RAP3; apo-AV; apolipoprotein A5; regeneration-associated protein 3;
APOBEC3G
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
APOBEC3G; apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G; DNA dC-> dU-editing enzyme APOBEC-3G; bK150C2.7; CEM15; dJ494G10.1; FLJ12740; MDS019; APOBEC-related protein 9; dU editing enzyme; ph;
APOC3
apolipoprotein C-III
APOC3; apolipoprotein C-III; APOCIII; MGC150353; apo-CIII; apoC-III; apolipoprotein C3; OTTHUMP00000043270; OTTHUMP00000069353;
APOC4
apolipoprotein C-IV
APOC4; apolipoprotein C-IV; APO C4; Apo CIV; APOC 4; ApoC IV; Apolipoprotein C IV; apolipoprotein C4; APO-CIV; APOC-IV;
APOF
apolipoprotein F
APOF; apolipoprotein F; lipid transfer inhibitor protein; LTIP; Apo-F; MGC22520; DKFZp781G18150;
APOL1
apolipoprotein L, 1
APOL1; apolipoprotein L, 1; APOL; apolipoprotein L1; APO L; Apo-L; APOL I; ApoL-I; APOL1_HUMAN; APOLI; Apolipoprotein L; Apolipoprotein L I; Apolipoprotein L-I; OTTHUMP00000028705; OTTHUMP00000197952; OTTHUMP00000197984; OTTHUMP00000197985; OTTHUMP00000197986; OTTHUMP00000197987; OTTHUMP00000198062; FSGS4;
APOL3
apolipoprotein L, 3
APOL3; apolipoprotein L, 3; apolipoprotein L3; APOLIII; CG12 1; ApoL III; Apolipoprotein L 3; Apolipoprotein L III; Apolipoprotein LIII; TNF inducible protein CG12 1; CG12_1; apoL-III; OTTHUMP00000198071; OTTHUMP00000198072; OTTHUMP00000198073; apolipoprotein L-III; TNF-inducible protein CG12-1; CG121;
APOO
apolipoprotein O
APOO; apolipoprotein O; FAM121B, family with sequence similarity 121B; MGC4825; My025; brain my025; family with sequence similarity 121B; FAM121B;
POLI
polymerase (DNA directed) iota
POLI; polymerase (DNA directed) iota; RAD3OB, RAD30B; DNA polymerase iota; Eta 2; ETA2; RAD 30B; RAD30 homolog B; RAD30B; RAD3OB; polymerase (DNA-directed), iota;
APOB48R
APOBR apolipoprotein B receptor
APOB48R; APOB100R; apolipoprotein B receptor; apoB-48R; apolipoprotein B48 receptor; apolipoprotein B-48 receptor; apolipoprotein B100 receptor; apolipoprotein B-100 receptor;
APOBEC3C
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C
APOBEC3C; apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C; probable DNA dC-> dU-editing enzyme APOBEC-3C; APOBEC1L; ARDC2; ARDC4; ARP5; bK150C2.3; PBI; Phorbolin I protein; APOBEC1 like; Apolipoprotein B mRNA editing enzyme catalytic polypeptide like 3C; MGC19485; Probable DNA dC dU editing enzyme APOBEC 3C; phorbolin I; A3C;
APOL6
apolipoprotein L, 6
APOL6; apolipoprotein L, 6; apolipoprotein L6; APOL VI; APOLVI; DKFZp667M075; FLJ38562; FLJ90164; MGC57495; 2310076O14Rik; Apolipoprotein L VI; OTTHUMP00000197934; apolipoprotein L-VI; APOL-VI;
LRP8
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor
LRP8; low density lipoprotein receptor-related protein 8, apolipoprotein e receptor; low-density lipoprotein receptor-related protein 8; APOER2; ApoE receptor 2; MCI1; LRP-8; HSZ75190;
PVRL4
poliovirus receptor-related 4
PVRL4; poliovirus receptor-related 4; poliovirus receptor-related protein 4; LNIR; nectin 4; PRR4; Ig superfamily receptor LNIR; Nectin-4; Processed poliovirus receptor-related protein 4; PVRL4_HUMAN; OTTHUMP00000029698; EDSS1;
APOBEC1
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1
APOBEC1; apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1; C-> U-editing enzyme APOBEC-1; APOBEC 1; BEDP; CDAR1; HEPR; apolipoprotein B mRNA-editing enzyme 1; apolipoprotein B mRNA editing enzyme complex-1;
APOL5
apolipoprotein L, 5
APOL5; apolipoprotein L, 5; apolipoprotein L5; APOLV; apolipoprotein L-V; APOL-V;
APOBEC2
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2
APOBEC2; apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2; probable C-> U-editing enzyme APOBEC-2; ARCD1; ARP1; Apolipoprotein B mRNA editing enzyme catalytic polypeptide 2; Apolipoprotein B mRNA editing enzyme catalytic polypeptide like 2; MGC128604; apolipoprotein B mRNA editing enzyme, catalytic polypeptide 2;
APOBEC3B
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B
APOBEC3B; apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B; probable DNA dC-> dU-editing enzyme APOBEC-3B; FLJ21201; phorbolin 3; PHRBNL; phorbolin 2; phorbolin-2/3; cytidine deaminase;
APOLD1
apolipoprotein L domain containing 1
APOLD1; apolipoprotein L domain containing 1; apolipoprotein L domain-containing protein 1; DKFZP434F0318; FLJ25138; Apolipoprotein L domain containing protein 1; Vascular early response gene protein; VERGE;
APOBEC3D
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3D
APOBEC3D; apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3D; APOBEC3E, apolipoprotein B mRNA editing enzyme, catalytic polypeptide like 3D (putative) , apolipoprotein B mRNA editing enzyme, catalytic polypeptide like 3E pseudogene; probable DNA dC-> dU-editing enzyme APOBEC-3D; ARP6; DNA dC-> apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3E pseudogene; APOBEC3E; APOBEC3DE;
APOBEC3F
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F
APOBEC3F; apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F; DNA dC-> dU-editing enzyme APOBEC-3F; ARP8; BK150C2.4.MRNA; KA6; Apolipoprotein B mRNA editing enzyme, catalytic polypeptide like 3F; Induced upon T cell activation; OTTHUMP00000199082; OTTHUMP00000199083; induced upon T-cell activation; apolipoprotein B mRNA editing enzyme cytidine deaminase; apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3F;
APOL2
apolipoprotein L, 2
APOL2; apolipoprotein L, 2; apolipoprotein L2; APOL II; apolipoprotein L II; 9830006J20Rik; APOL-II; APOL3; Apol8; ApoLII; Apolipoprotein LII; ApolipoproteinL2; apolipoprotein L-II;
APOL4
apolipoprotein L, 4
APOL4; apolipoprotein L, 4; apolipoprotein L4; APOLIV; APOL IV; Apolipoprotein L IV; CTA 212A2.2; OTTHUMP00000028937; apolipoprotein L-IV; APOL-IV;
APOBEC4
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 4 (putative)
APOBEC4; apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 4 (putative); C1orf169, chromosome 1 open reading frame 169; putative C-> U-editing enzyme APOBEC-4; FLJ25691; MGC26594; RP1 127C7.4; a;
APOBEC3H
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H
APOBEC3H; apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H; DNA dC-> dU-editing enzyme APOBEC-3H; ARP10; APOBEC related protein 10; Apolipoprotein B mRNA editing enzyme catalytic polypeptide like 3H; ARP 10; ARP-10; APOBEC-related protein 10; apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3H;
APOBEC3A
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A
APOBEC3A; apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A; ARP3; phorbolin I; PHRBN;
PVRIG
poliovirus receptor related immunoglobulin domain containing
PVRIG; poliovirus receptor related immunoglobulin domain containing; transmembrane protein PVRIG; C7orf15; MGC2463; Poliovirus receptor-related immunoglobulin domain-containing protein; PVRIG_HUMAN;
APOOL
apolipoprotein O-like
APOOL; apolipoprotein O-like; chromosome X open reading frame 33 , CXorf33, FAM121A, family with sequence similarity 121A; AAIR8193; UNQ8193; CXorf33; FAM121A; Family with sequence similarity 121A; MGC129748;
APOA1BP
apolipoprotein A-I binding protein
APOA1BP; apolipoprotein A-I binding protein; apolipoprotein A-I-binding protein; AIBP; apoA I binding protein; MGC119143; MGC119144; MGC119145; YJEFN1; AI BP; Apolipoprotein A I binding protein; YjeF N terminal domain containing protein 1; AI-BP; yjeF_N1; apoA-I binding protein; yjeF N-terminal domain-containing protein 1;